BlackRock Advisors’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $10.4M | Buy |
31,412
+4,893
| +18% | +$1.62M | 0.01% | 825 |
|
|
2016
Q3 | $7.09M | Buy |
26,519
+6,290
| +31% | +$1.68M | 0.01% | 974 |
|
|
2016
Q2 | $2.68M | Buy |
20,229
+414
| +2% | +$54.8K | ﹤0.01% | 1301 |
|
|
2016
Q1 | $3.5M | Buy |
19,815
+4,455
| +29% | +$786K | ﹤0.01% | 1200 |
|
|
2015
Q4 | $3.83M | Sell |
15,360
-5
| -0% | -$1.25K | ﹤0.01% | 1163 |
|
|
2015
Q3 | $4.32M | Buy |
15,365
+9,595
| +166% | +$2.7M | ﹤0.01% | 1118 |
|
|
2015
Q2 | $801K | Hold |
5,770
| – | – | ﹤0.01% | 1792 |
|
|
2015
Q1 | $949K | Buy |
5,770
+80
| +1% | +$13.2K | ﹤0.01% | 1566 |
|
|
2014
Q4 | $854K | Sell |
5,690
-20
| -0.4% | -$3K | ﹤0.01% | 1565 |
|
|
2014
Q3 | $761K | Sell |
5,710
-540
| -9% | -$72K | ﹤0.01% | 1598 |
|
|
2014
Q2 | $1.18M | Sell |
6,250
-10
| -0.2% | -$1.89K | ﹤0.01% | 1367 |
|
|
2014
Q1 | $1.59M | Buy |
+6,260
| New | +$1.59M | ﹤0.01% | 1250 |
|